MUCOEPIDERMOID CARCINOMA
Clinical trials for MUCOEPIDERMOID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOEPIDERMOID CARCINOMA trials appear
Sign up with your email to follow new studies for MUCOEPIDERMOID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare salivary gland cancer
Disease control Recruiting nowThis study tests a new drug (MRG003) alone or with another drug (putrelimab) in people with salivary gland cancer that has come back or spread. The goal is to see if these treatments can shrink tumors or stop them from growing. About 90 adults will take part, and the study is not…
Matched conditions: MUCOEPIDERMOID CARCINOMA
Phase: PHASE2 • Sponsor: Ji Dongmei • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental drug targets Hard-to-Treat salivary gland cancers
Disease control Recruiting nowThis phase 2 trial tests whether the drug sacituzumab govitecan can help control salivary gland cancer that has come back or spread to other parts of the body. About 30 adults whose cancer cannot be removed by surgery or cured with radiation will receive the drug through an IV. R…
Matched conditions: MUCOEPIDERMOID CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC